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Purpose
HLA class I-specific killer cell immunoglobulin-like recep-
tors (KIR) gene and HLA gene combinations have been
associated with autoimmune uveitis (e.g., birdshot choriore-
tinopathy (BCR) and Vogt-Koyanagi-Harada syndrome
(VKH)). In oligoarticular juvenile idiopathic arthritis (JIA),
uveitis is one of the most serious complications, affecting
approximately 20% of patients. Multiple studies suggest
there are HLA Class II associations with chronic anterior
uveitis in JIA; however, there is a paucity of evidence
demonstrating Class I associations. Given the importance
of HLA Class I and KIR gene combinations in other forms
of autoimmune uveitis, we hypothesized that an interplay
between these genes may contribute to the pathogenesis of
uveitis in JIA. To test this hypothesis, we are: 1) determin-
ing HLA Class I and KIR gene associations in children with
JIA with and without uveitis and comparing them with
healthy controls, and 2) determining associations between
clinical course and HLA Class I - KIR gene associations.
Methods
Study population included pediatric patients with JIA, with
and without uveitis. DNA samples are typed for 16 KIR
genes using a gene-specific PCR typing system. HLA-A, -B
and -C typing are performed by sequence-specific oligonu-
cleotide hybridization methods. We analyzed the presence
or absence of 16 KIR genes in patients with uveitis,
patients without uveitis, and published healthy controls
(n = 429). The JIA clinical phenotype, including medica-
tion use and assessment of functional outcome by the
Children’s Health Assessment Questionnaire (CHAQ),
were compared with genotype. Data were analyzed by stu-
dent’s t-test, linear regression, and multivariate logistic
regression modeling. Further testable genetic hypotheses
were generated with Weighted Gene Co-expression Net-
work Analysis (WGCNA) or cluster analysis modeling.
Results
A total of 29 (52% with uveitis) blood samples have
been collected, and the 16 KIR genes have been geno-
typed. In previous studies, KIR3DL3, -3DP1, -2DL4,
-3DL2 were considered to be framework genes and were
present in all adults with autoimmune uveitis. These
findings were replicated in our pediatric sample (p =
0.0001); there were 2 additional KIR genes present in
100% of the tested individuals (KIR2DL1, KIR2DP1).
There was no association of KIR genotype in oligoarti-
cular JIA patients with or without uveitis as compared
with healthy control population nor an association of
KIR genotype in oligoarticular JIA patients with uveitis
compared to oligoarticular JIA patients without uveitis.
Similarly, there was no association seen with KIR geno-
type and polyarticular JIA patients (n = 6) with or with-
out uveitis versus healthy control population.
Conclusion
In this small sample size, we did not find an association
between KIR gene frequencies and JIA-associated uvei-
tis. To reduce the possibility of a Type I error, we are
expanding our sample size and we will compare the KIR
genotypes to HLA types. Uveitis remains a significant
risk for disability in JIA (e.g., cataracts, visual loss);
therefore, developing a risk prediction model may allow
for aggressive screening and disability prevention.
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